Saturday 17 October 2026 Export ATRA’s income statement to Excel — free account

Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $120.8 million, down 6.33% from fiscal 2024. In the quarter to June 2026, revenue fell 96.4%, EPS fell 260.0% and free cash flow grew 52.1%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

9.18 0.47 −4.87%

Follow ATRA

Alert me

Market cap: $96.9M
P/E: 0.0×
Fwd P/E: −8.4×
Dividend yield: —
F-score: 5/9
Altman Z: −125.91
Beneish M: 16.88
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	3	3	5	5	+8 more TTM periods Free account
ROE Full definition →	46.33%	20.49%	(48.15%)	(36.80%)
ROA Full definition →	(57.62%)	(23.08%)	50.55%	27.07%
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(248.19%)	(143.81%)	(1,239.59%)	4,482.95%
Average Days of Receivables Full definition →	18.74	0.00	3.79	4.60
Free Cash Flow per Share Full definition →	(1.46)	(1.84)	(3.99)	(5.12)
Free Cash Flow Full definition →	(21.89)	(25.87)	(50.08)	(69.41)
Capital Expenditures Full definition →	—	—	0.86	0.30
Other line items
Cash ROIC Full definition →	80.72%	89.37%	166.83%	302.81%
Accounts Receivable Turnover Full definition →	6.88	0.00	93.33	70.09
Accounts Payable Turnover Full definition →	0.41	0.89	9.44	22.65
Inventory Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	563.22	259.20	2.19	4.16
Days of Inventory on Hand Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	67.99%	43.98%	31.00%	43.70%
Selling, General and Administrative Expense of Revenue Full definition →	253.07%	79.41%	21.74%	20.68%
Share Based Compensation of Revenue Full definition →	62.72%	27.19%	8.07%	9.27%
Interest Coverage Full definition →	(5.04)	(1.75)	9.46	6.70
Operating CF/Net income Full definition →	1.31	2.73	(1.56)	(2.98)
Depreciation/Fixed assets Full definition →	2.44	6.36	32.53	21.31
Capex/Depreciation Full definition →	0.00	0.00	0.36	0.10
Revenue per Share Full definition →	0.41	1.64	9.63	11.20
Operating CF per Share Full definition →	(1.46)	(1.84)	(4.06)	(5.14)
Capex per Share Full definition →	0.00	0.00	0.07	0.02
Capex to Sales Full definition →	0.00	0.00	(0.01)	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly